Benjamin Wolozin

28.9k citations

160 papers · 19.3k indexed · 7 hit papers · h-index 65

Impact in

Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Amyotrophic Lateral Sclerosis Research
Cellular and Molecular Neuroscience top 0.2%
- Nuclear Receptors and Signaling
- Neuroscience and Neuropharmacology Research

Papers in

Aging 9
Neurology 44
- Parkinson's Disease Mechanisms and Treatments 30
- Amyotrophic Lateral Sclerosis Research 15
- Neuroinflammation and Neurodegeneration Mechanisms 10

Co-authors: Leonard Petrucelli Klaus‐Peter Lesch Dennis L. Murphy Pavel Ivanov Peter Davies Liqun Liu‐Yesucevitz John Hardy Tara Vanderweyde
Journals: Journal of Biological Chemistry (11 papers)Journal of Neuroscience (7 papers)Journal of Alzheimer s Disease (6 papers)Neurodegenerative Diseases (5 papers)Proceedings of the National Academy of Sciences (5 papers)
Partner nations: United States Germany Japan

In The Last Decade

Benjamin Wolozin

157 papers receiving 19.0k citations

Hit Papers

7 papers align trajectories log scale

Stress granules and neurodegeneration 2019 · 491 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Nature reviews. Neuroscience
2018 Trends in Cell Biology
2015 Nature Neuroscience
2013 Gerontology
2000 Archives of Neurology
1994 Journal of Neural Transmission
1986 Science

Peers

Countries citing papers authored by Benjamin Wolozin

Since Specialization

Citations

This map shows the geographic impact of Benjamin Wolozin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Wolozin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Wolozin more than expected).

Fields of papers citing papers by Benjamin Wolozin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Wolozin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Wolozin. The network helps show where Benjamin Wolozin may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Wolozin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Wolozin Line = papers co-authored together Benjamin Wolozin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	RNA Granules at the Crossroads of Synaptic Dysfunction and Neurodegeneration Journal of Neurochemistry ·周云鹏, حيدر فليح حسن, 侯菲, Ioannis Sotiropoulos, Benjamin Wolozin, Joana Silva	2025	0
2	Development of Orally Available, Brain Penetrant Compound That Reduces Tau Pathology Alzheimer s & Dementia ·Benjamin Wolozin, Peter E.A. Ash, Amit Berson, Morgan G. Stykel, Christopher R. Murphy, Koichiro TSUNEWAKI, G R Larsen	2024	0
3	GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease-like filaments Proceedings of the National Academy of Sciences ·Л. Ю. Топурия, Alain Ibáñez de Opakua, Jeffrey A. Purslow, Simon A. Fromm, Debdeep Chatterjee, 幸夫東田, Diao Yu-Na, Д А Хурманенок, Benjamin Wolozin, Markus Zweckstetter	2024	14
4	Human herpesvirus 8 ORF57 protein is able to reduce TDP-43 pathology: network analysis identifies interacting pathways Human Molecular Genetics ·郭晨光, 宇坤唐, G. N. Orekhov, LI Qi-gui, J Q Zhang, 高秉喜, S. Ja. Trofimov, Ahmad S. Khalil, Andrew Emili, Benjamin Wolozin	2023	1
5	Identification of circRNAs linked to Alzheimer's disease and related dementias Alzheimer s & Dementia ·Д А Хурманенок, Alice Goyanes, 涼蜂谷, نايف مستور السلمي, Thor D. Stein, Lindsay A. Farrer, Benjamin Wolozin, Xiaoling Zhang	2023	29
6	Proteostasis Deregulation in Neurodegeneration and Its Link with Stress Granules: Focus on the Scaffold and Ribosomal Protein RACK1 Cells ·Mirco Masi, Alessandro Attanzio, Marco Racchi, Benjamin Wolozin, K. Kim, Fabrizio Biundo, Erica Buoso	2022	11
7	Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis Journal of Neuroscience ·Shelby E. Meier, T. Vittori, Danielle N. Lyons, Jennifer Rodriguez-Rivera, 里枝澤井, Sarah N. Fontaine, Ted Polley, Jing Chen, Benjamin Wolozin, Harry LeVine, Haining Zhu, Jose F. Abisambra	2016	128
8	Role of Stress Granules and RNA-Binding Proteins in Neurodegeneration: A Mini-Review Gerontology ·Tara Vanderweyde, Malaika Siddiqui, Liqun Liu‐Yesucevitz, Benjamin Wolozin Hit paper breakdown →	2013	630
9	Neuronal-Specific Overexpression of a Mutant Valosin-Containing Protein Associated with IBMPFD Promotes Aberrant Ubiquitin and TDP-43 Accumulation and Cognitive Dysfunction in Transgenic Mice American Journal Of Pathology ·Carlos J. Rodríguez‐Ortiz, 定方美恵子, David Cheng, G. Chen, Mathew Blurton‐Jones, Benjamin Wolozin, Frank M. LaFerla, Masashi Kitazawa	2013	26
10	The heat shock transcription factor Hsf1 is downregulated in DNA damage–associated senescence, contributing to the maintenance of senescence phenotype Aging Cell ·Geunwon Kim, Anatoli B. Meriin, Vladimir L. Gabai, Elisabeth Christians, Ivor J. Benjamin, Andrew A. Wilson, Benjamin Wolozin, Michael Y. Sherman	2012	62
11	Watching Worms Whither Progress in molecular biology and translational science ·Benjamin Wolozin, Christopher V. Gabel, Andrew Ferree, Maria Guillily, Atsushi Ebata	2011	41
12	Local RNA Translation at the Synapse and in Disease: Figure 1. Journal of Neuroscience ·Liqun Liu‐Yesucevitz, Gary J. Bassell, Aaron D. Gitler, Anne C. Hart, Eric Klann, Joel D. Richter, Stephen T. Warren, Benjamin Wolozin	2011	239
13	Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2) Journal of Biological Chemistry ·Diane Chan, Allison Citro, Joanna M. Cordy, 连建伟, Benjamin Wolozin	2011	96
14	Lipid-Lowering Treatment Is Related to Decreased Risk of Dementia: A Population-Based Study (FINRISK) Neurodegenerative Diseases ·Alina Solomon, Risto Sippola, H. Soininen, Benjamin Wolozin, J Tuomilehto, Tiina Laatikainen, Miia Kivipelto	2010	19
15	β-Synuclein Reduces Proteasomal Inhibition by α-Synuclein but Not γ-Synuclein Journal of Biological Chemistry ·Heather M. Snyder, Hui-xin Jing, Cindy H. Hsu, Makoto Hashimoto, Irina Surgucheva, Barry W. Festoff, Andrei Surguchov, Elise Manon Lefèvre, Andreas Matouschek, Benjamin Wolozin	2005	48
16	Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease Neurobiology of Disease ·H. Fai Poon, Mark Frasier, Xue-Feng Lai, Vittorio Calabrese, Benjamin Wolozin, D. Allan Butterfield	2005	131
17	Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients Aging Cell ·Hossein Ghanbari, Daniel C. Littlefield, Peggy L.R. Harris, Paul K. Jones, do Amaral A.S., Rudolph J. Castellani, Benjamin Wolozin, Mark A. Smith, George Perry	2004	63
18	Regulation of Apoptosis by Presenilin 1 Neurobiology of Aging ·Benjamin Wolozin, Oldøich Robek, James Palacino	1998	55
19	Physiological levels of β-amyloid peptide stimulate protein kinase C in PC12 cells Brain Research ·Ying Luo, David B. Hawver, O. Abu Samak, Trey Sunderland, G. S. Roth, Benjamin Wolozin	1997	32
20	Direct sequencing of the reserpine-sensitive vesicular monoamine transporter complementary DNA in unipolar depression and manic depressive illness Psychiatric Genetics ·Klaus‐Peter Lesch, J. Groß, Benjamin Wolozin, Ernst Franzek, Dietmar Bengel, P. Riederer, Dermot Murphy	1994	12

About Benjamin Wolozin

Benjamin Wolozin is a scholar working on Aging, Neurology, Physiology, Cellular and Molecular Neuroscience and Neurology, having authored 160 papers that have together received 19.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (63 papers), Parkinson's Disease Mechanisms and Treatments (30 papers), RNA Research and Splicing (28 papers), Amyotrophic Lateral Sclerosis Research (15 papers), Neuroscience and Neuropharmacology Research (14 papers), Nuclear Receptors and Signaling (11 papers), Genetic Neurodegenerative Diseases (10 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). The work is most often cited by research in Neurology (4.7k citations), Neurology (2.5k citations), Cellular and Molecular Neuroscience (4.7k citations), Physiology (6.7k citations) and Biological Psychiatry (574 citations). Benjamin Wolozin has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Leonard Petrucelli, Klaus‐Peter Lesch, Dennis L. Murphy, Pavel Ivanov, Peter Davies, Liqun Liu‐Yesucevitz, John Hardy, Tara Vanderweyde, Peter Riederer and Tsuneya Ikezu. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience, Journal of Alzheimer s Disease, Neurodegenerative Diseases and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact